Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
D000818:Animals; D030801:Animals, Genetically Modified; D001402:B-Lymphocytes / Q000276:immunology / Q000502:physiology*; D015536:Down-Regulation; D004854:Herpesvirus 4, Human / Q000502:physiology*; D008213:Lymphocyte Activation; D051379:Mice; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism*; D015398:Signal Transduction; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic / Q000502:physiology*; D014763:Viral Matrix Proteins / Q000502:physiology*; D017735:Virus Latency
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D011947:Receptors, Antigen, B-Cell; D014157:Transcription Factors; D014763:Viral Matrix Proteins